What is the fair value of Alcon AG (NYSE-ALC) stock?

The current fair value estimate for Alcon AG (NYSE-ALC) is $78.51. This implies an estimated upside of 20.7% versus the current market price.

Is Alcon AG (NYSE-ALC) undervalued or overvalued?

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 20.7% versus the current market price.

What is the analyst price target for NYSE-ALC stock?

The available analyst price target for Alcon AG (NYSE-ALC) is $85.24. The analyst target implies estimated upside of 31.1%.

How is the financial health of Alcon AG?

The current financial health read for Alcon AG (NYSE-ALC) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

When is Alcon AG's next earnings date?

The next earnings date currently listed for Alcon AG (NYSE-ALC) is November 10, 2026.

Does Alcon AG (NYSE-ALC) pay dividends?

Based on the current data, dividend yield is 0.4%.

What is the P/E ratio for Alcon AG (NYSE-ALC)?

The current P/E ratio listed for Alcon AG (NYSE-ALC) is 49.1x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

What is the market capitalization of Alcon AG?

The current market capitalization listed for Alcon AG is 31.559 B.

What is the enterprise value of Alcon AG?

The current enterprise value listed for Alcon AG is 34.569 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

What is the ticker symbol for Alcon AG?

The ticker symbol for Alcon AG is NYSE-ALC, and the stock is listed on NYSE.

Where is Alcon AG (NYSE-ALC) listed?

Alcon AG (NYSE-ALC) is listed on NYSE.

What is the debt-to-total-capital ratio for Alcon AG?

The current debt-to-total-capital ratio listed for Alcon AG is 14.5%, which helps investors evaluate the company’s financing structure and leverage profile.

What is the free float for Alcon AG?

The free float listed for Alcon AG is 99.7%. Free float helps investors understand how much of the share base is available for public trading.

Alcon AG (ALC) Fair Value & Stock Analysis

Alcon AG (ALC)

Alcon AG is a healthcare company focused on eye care products worldwide. Listed on the NYSE as common stock under the ticker ALC, the company operates through two main segments, Surgical and Vision Care. Its Surgical business includes equipment, diagnostics, intraocular lenses, implantables, and a range of consumables used in ophthalmic procedures. The Vision Care segment covers contact lenses and eye health products. Alcon’s portfolio spans cataract surgery systems and digital tools, refractive surgery products used in LASIK procedures, vitreoretinal instruments, and contact lenses, along with products for dry eye, glaucoma, ocular allergies, and lens care. The company was founded in 1945 and is headquartered in Geneva, Switzerland. It was previously known as Alcon Universal S.A. before adopting the Alcon Inc. name in 2001.

Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.

Ticker	Fair Value	Fair Value Upside/Downside	Fair Value Rating	Analyst Price Target	Analyst Target Upside/Downside	Analyst Target Rating	Overall Financial Health	Dividend Yield	Next Earnings Date	P/E Ratio	Price-to-Book Ratio	Price-to-Sales Ratio	Market Cap	Enterprise Value	Total Debt / Total Capital	Free Float / Shares Outstanding	Altman Z-Score	Payout Ratio	Free Cash Flow / Net Income
NYSE-ALC	$78.51	20.7% Upside	Undervalued	$85.24	31.1% Upside	Undervalued	Good	0.4%	November 10, 2026	49.1x	1.5x	2.9x	31.559 B	34.569 B	14.5%	99.7%	8.0	27.1%	270.6%